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Abstract
Background: Mesencephalic dopaminergic neurons (mDA) and serotonergic (5-HT) neurons are clinically important ventral
neuronal populations. Degeneration of mDA is associated with Parkinson’s disease; defects in the serotonergic system are
related to depression, obsessive-compulsive disorder, and schizophrenia. Although these neuronal subpopulations reveal
positional and developmental relationships, the developmental cascades that govern specification and differentiation of
mDA or 5-HT neurons reveal missing determinants and are not yet understood.
Methodology: We investigated the impact of the transcription factor Sim1 in the differentiation of mDA and rostral 5-HT
neurons in vivo using Sim1-/- mouse embryos and newborn pups, and in vitro by gain- and loss-of-function approaches.
Principal Findings: We show a selective significant reduction in the number of dorsal raphe nucleus (DRN) 5-HT neurons in
Sim1-/- newborn mice. In contrast, 5-HT neurons of other raphe nuclei as well as dopaminergic neurons were not affected.
Analysis of the underlying molecular mechanism revealed that tryptophan hydroxylase 2 (Tph2) and the transcription factor
Pet1 are regulated by Sim1. Moreover, the transcription factor Lhx8 and the modulator of 5-HT1A-mediated neurotransmitter
release, Rgs4, exhibit significant higher expression in ventral hindbrain, compared to midbrain and are target genes of Sim1.
Conclusions: The results demonstrate for the first time a selective transcription factor dependence of the 5-HT cell groups,
and introduce Sim1 as a regulator of DRN specification acting upstream of Pet1 and Tph2. Moreover, Sim1 may act to
modulate serotonin release via regulating RGS4. Our study underscores that subpopulations of a common neurotransmitter
phenotype use distinct combinations of transcription factors to control the expression of shared properties.
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Introduction
Cell and neuron subpopulations in the CNS differentiate in
stereotypic, defined positions along the anterior-posterior and
dorso-ventral axes of the neural tube and exhibit a cell-type-
specific transcriptional code [1]. Among neuronal subpopulations,
mesencephalic dopaminergic neurons (mDA) and serotonergic (5-
HT) neurons are of particular interest, because of their
involvement in neurological and degenerative diseases. Degener-
ation of mDA is associated with Parkinson’s disease [2], defects in
the serotonergic system are related with depression, obsessive-
compulsive disorder, and schizophrenia [3].
During development of the CNS, mDA and 5-HT neurons are
among the first to emerge [4]. Because of their early onset 5-HT
neurons are even regarded to play a role in several differentiation
processes, acting as a growth and differentiation promoting factor
in addition to being a neurotransmitter. 5-HT neurons are
involved in the differentiation of precursor cells in their target
regions. Both mDA and 5-HT neurons develop as distinct cell
groups and have a close ontogenetic relationship: their respective
Otx2- and Gbx2-expressing progenitors are located adjacent on
either side of the midbrain-hindbrain boundary [5], their
development critically depends on Shh and FGF8 [6], and the
transcriptional code controlling differentiation of progenitors
toward dopaminergic or serotonergic cell fate shares common
determinants, such as Nkx2.2, Lmx1b, and Mash1 [7–9]. However,
the transcriptional equipment of mDA additionally includes
Lmx1a, Nurr1, Pitx3, and En1/2 [10], whereas differentiation of
rostral 5-HT neurons involves Pet1 and Gata2 [11,12]. In spite of
numerous studies, the transcriptional network and the develop-
mental cascades that govern specification and early differentiation
of dopaminergic or serotonergic neurons reveal missing determi-
nants, and are not yet understood.
The Drosophila CNS midline cells derive from the mesectoderm
that gives rise to CNS midline progenitor cells, and their
development requires expression of the bHLH/PAS domain
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activates expression of rho, en, and egfr [17]. The two mammalian
homologs, Sim1 and Sim2 [18], reveal differential expression
patterns during mouse embryogenesis [19]. Sim1-/- and Sim2-/-
mice die perinatally due to hypothalamic and respiratory defects,
respectively [20,21]. Interestingly, Gata2, expressed in postmitotic
serotonergic progenitors, and Gdnf, a survival promoting factor for
mDA [22], represent target genes of Sim1 [23]. Moreover, Sim1
has shown to be upregulated in mouse ventral regions of the
CNS (M. Wiehle, N. Osterberg, and E. Roussa, unpublished
observations).
Here we demonstrate the impact of Sim1 in the differentiation of
mDA and rostral 5-HT neurons using Sim1 gain- and loss-of-
function experiments in vitro, and Sim1 deficient mice in vivo. The
results show that development of mDA is Sim1-independent.
Conversely, Sim1 represents an important regulator in the
development of a subpopulation of rostral 5-HT neurons, the
dorsal raphe nucleus, acting upstream of Pet1 and Tph2. Moreover,
we have identified target genes of Sim1, namely Lhx8, RGS4, and
Brn3.2 being upregulated in ventral hindbrain, compared to
ventral midbrain, and Lhx8 and RGS4 as putative candidates
involved in the specification of mouse rostral serotonergic neurons.
Results
Sim1 is expressed in mouse ventral midbrain and ventral
hindbrain and co-localizes with TH and 5-HT
As the first step to investigate potential involvement of Sim1 in
the differentiation of mDA and 5-HT neurons, we have
determined that Sim1 is expressed in these brain areas at crucial
developmental stages. Fig. 1A shows RT-PCR analysis of mouse
E12 ventral midbrain, isthmus, and ventral hindbrain tissue using
specific Sim1 primers. A transcript of the expected size of
,319 bp could be amplified from all probes examined (Fig. 1A,
lanes 5–7). Sim1 expression was considerably stronger in mouse
ventral midbrain, compared to hindbrain. Subsequently, cellular
localization of Sim1 with the late markers for dopaminergic and
serotonergic lineage, TH and 5-HT, respectively, has been
performed in newborn mice. Fig. 1B illustrates double immuno-
labeling for TH and Sim1 on fixed paraffin sections from mouse
midbrain at the area of substantia nigra pars compacta (SNc) and
ventral tegmental area (VTA). Sim1 was exclusively expressed in
cell nuclei, whereas TH showed an intracellular labeling pattern.
At higher magnification, a co-localization of Sim1 could be
observed with TH (Fig. 1C). However, whereas all TH positive
neurons showed additionally immunoreactivity for Sim1 (Fig. 1C,
arrows), many Sim1 immunopositive cells were devoid of TH
immunoreactivity (Fig. 1C, asterisks), indicating a broader
expression domain of Sim1. Similar results could be obtained in
all rostral serotonergic neurons of newborn mice. Fig. 1D and 1E
exemplarily illustrate double immunofluorescence for Sim1 (red)
and 5-HT (green) in the area of dorsal raphe nucleus (DRN). Sim1
was found always co-localized with 5-HT neurons. Again, in
several Sim1 positive cells 5-HT immunoreactivity could not be
detected.
Sim1 is required for the differentiation of a
subpopulation of mouse rostral serotonergic neurons,
but not for mesencephalic dopaminergic neurons
In Drosophila melanogaster, Sim is required for development of all
midline CNS cells [24]. We have investigated putative effects of
the mouse homolog Sim1 in the induction and specification of
ventral neuronal subpopulations, represented by mDA and rostral
5-HT neurons, in vivo.
Fig. 2A shows cell counts after immunohistochemistry of
midbrain TH immunopositive cells of fixed wild type (wt) and
Sim1-/- mutant mice embryos at E14.5. The results show no
significant differences in the number of midbrain TH immuno-
reactive neurons between wt and Sim1-/- mutant embryos
(p=0.4023, n=6). Similar results could be obtained in newborn
mice (P0) for TH immunoreactive cells of the substantia nigra and
ventral tegmental area (Fig. 2B; p=0.5220, n=6).
Analysis of the serotonergic system from wt (C) and Sim1-/-
mutants (D) at E14.5 showed that the total number of 5-HT
immunolabeled rostral serotonergic neurons was comparable
between Sim1-/- embryos and their wt littermates (Fig. 2E;
p=0.15, n=6). Similarly, in newborn mice (Fig. 2J), the total
number of rostral 5-HT immunopositive cells (i.e. raphe nuclei B5-
B9) showed no significant differences between wt (Fig. 2F) and
Sim1-/- (Fig. 2H; p=0.06, n=6). However, when 5-HT
immunoreactive neurons were quantified for each nucleus
separately, a significant decrease in the number of serotonergic
neurons in the dorsal raphe nucleus (DRN) was found in Sim1-/-
(Figs. 2I), compared to the wt (Figs. 2G; **p=0.009, n=6). In
contrast, the number of 5-HT immunopositive cells in the median
and paramedian raphe nuclei were comparable between wt and
Sim1 mutants (Fig. 2J; p=0.61 and p=0.27, respectively, n=6).
These data implicate a selective role for Sim1 in the
differentiation of a particular subset of rostral 5-HT neurons,
whereas induction, specification, and maintenance of mDA are
Sim1-independent.
MN9D cell line expresses dopaminergic and serotonergic
markers
Elucidation for the role of a gene of interest in the development
of mDA and 5-HT neurons can be complemented by an adequate
in vitro system that allows gain of function and loss of function
experiments. The MN9D cell line [25] expresses key dopaminergic
markers and has been used in studies dealing with differentiation
of dopaminergic neurons [26].
However, MN9D cells apparently express specific markers for
the serotonergic lineage as well, as assessed by RT-PCR analysis,
shown in Fig. 3A. Transcripts of the expected size for Gata2
(,110 bp, lane 3), expressed in mitotic and postmitotic seroto-
nergic progenitors, and for Pet1 (,109 bp, lane 4), exclusively
expressed in postmitotic 5-HT neurons, could be amplified from
MN9D cells cDNA. In addition, expression of TPH2 (,99 bp,
lane 5), a late specific marker for the serotonergic lineage, was also
found. The gene of interest, Sim1, showed only weak expression
level in MN9D cell line (,115 bp, lane 6). Moreover, besides
genes involved in induction of 5-HT phenotype, expression of
Nestin (,438 bp, lane 10), a marker for neural precursor cells, was
also expressed, indicating that the MN9D cell line is comprised of
a mixed cell population. Taken together, these results indicate that
MN9D cells represent a suitable in vitro model system to study the
molecular mechanisms underlying differentiation of mDA and 5-
HT neurons.
Fig. 3B illustrates RT-PCR analysis after overexpression of Sim1
in MN9D cells 24 h, 48 h, and 72 h after transfection of the cells
either with pcDNA3 expression vector (controls; ctl) or with
pcDNA3::Sim1 expression vector (Sim1), as described in Material
and Methods. Sim1 was expressed at high levels 24 h after
transfection with pcDNA3::Sim1, compared to the controls, and
remained at this level up to 72 h after transfection. Consistently,
western blot analysis using a specific anti-Sim1 antibody (Fig. 3C)
showed a prominent immunoreactive band at ,85.5 kDa (arrow),
corresponding to the molecular mass of full length Sim1. As shown
in Fig. 3C, in pcDNA3::Sim1-transfected MN9D cells Sim1
Sim1 and 5-HT Neuron Differentiation
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after transfection, compared to the MN9D cells that had been
transfected with pcDNA3 (lanes 1 and 3) expression vector.
Similar results were obtained 72 h after transfection (data not
shown).
Expression of early and late dopaminergic markers is not
affected by Sim1
We next examined whether Sim1 over-expression in the MN9D
cells has an impact on the expression of genes associated with
mDA or rostral 5-HT neurons.
Fig. 4A represents the western blot analysis of the MN9D
homogenate from the controls, i.e. cells transfected with pcDNA3
expression vector (ctl) and from Sim1-overexpressing cells 24 h
after transfection, using anti-GAPDH as a housekeeping gene and
Pitx3 or TH antibodies. Protein abundance of the dopaminergic
markers Pitx3 (,31.7 kDa, lanes 1 and 2) and TH (,41 kDa,
lanes 3 and 4) was comparable between controls and Sim1-
overexpressing cells (1.1660.50 fold; p=0.89, n=3 and
1.2760.35 fold p=0.72, n=5, for Pitx3 and TH, respectively).
Similar results were obtained in probes collected 48 h and 72 h
after transfection (data not shown).
Fig. 4B illustrates a representative immunoblot of homogenate
from MN9D controls and MN9D overexpressing Sim1, probed
with specific anti-Pet1 and anti-TPH2 antibodies. Using the anti-
Pet1 and anti-TPH2 antibody respective bands at ,35 kDa and at
Figure 1. Sim1 mRNA expression by RT-PCR and cellular localization of Sim1 in mouse tissues by immunohistochemistry. A: Sim1
transcript was detected in mouse E12 ventral hindbrain, ventral midbrain, and isthmus region using sim1 primers corresponding to nucleotides (nt)
736-756 and nt:1052-1032 of the mouse Sim1 gene (Genbank accession number: NM011376). B: double immunolabeling on mouse fixed paraffin
sections for TH (blue) and Sim1 (brown) showed Sim1 localization in the cell nucleus and cytoplasmic staining pattern for TH in midbrain substantia
nigra pars compacta (SNc) and ventral tegmental area (VTA). Inset at higher magnification shown in C: co-localization of TH and Sim1 is apparent.
Arrows point to cells that are immunopositive for both TH and Sim1. Asterisks indicate Sim1 positive, but TH negative cells. D, E: double
immunofluorescence for 5-HT (green) and Sim1 (red) in mouse hindbrain revealed co-localization of the proteins.
doi:10.1371/journal.pone.0019239.g001
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PLoS ONE | www.plosone.org 3 April 2011 | Volume 6 | Issue 4 | e19239Figure 2. Phenotype analysis for midbrain dopaminergic and rostral serotonergic neurons of Sim1-/- mutants. Counting of TH positive
cells after immunostaining in midbrain tissue sections revealed no differences in the number of midbrain dopaminergic neurons between wild type
(wt) and Sim1-/- mutants at embryonic day (E)14.5 (A) and newborn (P0; B). ns: not significant. C-D: 5-HT immunofluorescence in frontal sections of wt
(C) and Sim1-/- embryos (D) at E14.5 (DRN: dorsal raphe nucleus; Aq: aqueduct). E: Quantification of cell counts: numbers of 5-HT immunopositive
Sim1 and 5-HT Neuron Differentiation
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respective full length proteins. However, both Pet1 and TPH2
protein was significantly upregulated in MN9D cells overexpress-
ing Sim1, compared to the MN9D cells that had been transfected
with pcDNA3 vector (2.1560.32 fold, *p=0.04 and 2.6860.41
fold, *p=0.031, n=4 for Pet1 and TPH2, respectively).
Figure 3. MN9D cells, a suitable in vitro model system. A: Expression of determinants of the serotonergic lineage in the MN9D cell line by RT-
PCR. Gata2, Pet1, and Tph2 could be amplified from MN9D cells cDNA. The Sim1 primers used correspond to nucleotides (nt) 37-66 and nt:152-126 of
the mouse Sim1. In addition, expression of the neural stem cell marker nestin was also detected. B: RT-PCR analysis of Sim1 expression in MN9D cells
cDNA, 24 hours, 48 hours, and 72 hours after transfection of the cells with either pcDNA3::Sim1 or pcDNA3 expression vectors (ctl) and GAPDH as
housekeeping gene. Sim1 expression was clearly increased in pcDNA3::Sim1-transfected MN9D cells, compared to the pcDNA3-transfected cells. C:
Sim1 protein abundance by immunoblotting in homogenates of MN9D cells transfected either with pcDNA3::Sim1 or pcDNA3 expression vectors (ctl)
24 hours and 48 hours after transfection. The immunoblots were probed either with monoclonal antibody against GAPDH or with rabbit polyclonal
antibody against Sim1. Sim1 protein was significantly upregulated in pcDNA3::Sim1-transfected MN9D cells, compared to the pcDNA3-transfected
cells (**P,0.01 after densitometric analysis of the signal ratio Sim1: GAPDH and Student’s t-test, n=3). Arrow points to the band of the expected size.
The blots are representative for three different experiments. 30 mg protein was loaded per lane.
doi:10.1371/journal.pone.0019239.g003
cells were comparable between wt and Sim1-/-. F-J: Whereas quantification of cell counts revealed no statistical differences (ns) in the total number of
rostral 5-HT neurons, median raphe, and paramedian raphe 5-HT neurons between Sim1-/- (H) and their wt littermates (F), the number of 5-HT
immunoreactive cells in the dorsal raphe nucleus (DRN) was found significantly decreased in Sim1-/-, compared to the wild type. 5-HT
immunolabeling in mouse rostral raphe nuclei at P0 in wt (G) and Sim1 mutants (I). Arrow points to dorsal raphe nucleus (DRN). Aq: aqueduct.
doi:10.1371/journal.pone.0019239.g002
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not Mash1 and Gata2, are controlled by Sim1
To further understand the mechanism underlying the effect of
Sim1 on serotonergic neurons, we investigated whether expression
of early and late determinants of the serotonergic lineage might be
influenced by Sim1. Fig. 5 illustrates quantitative real-time PCR
(qRT-PCR) analysis of relative expression of Gata2, Mash1, Pet1,
and Tph2 in MN9D cells transfected either with control or Sim1
expression vectors 24 h, 48 h, and 72 h. Sim1 overexpression had
no effect on Gata2 (A) and Mash1 (B) expression at all time points.
By contrast, as shown in Fig. 5C, expression of Pet1, a transcription
factor exclusively expressed in postmitotic 5-HT neurons, was
found significantly upregulated in Sim1 overexpressing MN9D
cells, relative to the controls, at 48 h and 72 h after transfection
(**p=0.003 and *p=0.01 for 48 h and 72 h, respectively; n=3).
Moreover, expression of Tph2 (D), the rate-limiting enzyme in
brain serotonin biosynthesis, was significantly upregulated in Sim1
overexpressing cells, compared to the controls, at 48 h and 72 h as
well (**p=0.006 and ***p=0.0009 for 48 h and 72 h, respective-
ly; n=3). These data indicate that Pet1 and Tph2 expression is
likely controlled by Sim1, either directly or indirectly.
Expression of Sim1 target genes RGS4, Lhx8, and Brn3.2,i s
upregulated in ventral hindbrain
To investigate the difference between the transcriptional profiles
between rostral 5-HT and mDA at their early stages of
development we have screened for genes that are upregulated in
mouse ventral hindbrain, compared to ventral midbrain tissue at
E11.5 and therefore could be considered as potential candidates
involved in the induction of 5-HT neurons. Fig. 6A shows qRT-
PCR analysis and relative mRNA expression of the transcription
factors Brn3.2 and Lhx8, as well as for RGS4, a regulator of G
protein signalling and modulator of 5-HT1A-mediated neurotrans-
mitter release, in mouse E11.5 ventral hindbrain tissue, compared
to ventral midbrain. The results showed significant upregulation of
Lhx8 by approximately 12.82 fold in mouse ventral hindbrain,
compared to ventral midbrain. Expression of Brn3.2 was found
,6.16 fold upregulated in ventral hindbrain. Finally, RGS4
expression was upregulated by approximately 2.81 fold in the
ventral hindbrain, thus considerably lower than Lhx8 and Brn3.2,
but still significantly higher than in mouse ventral midbrain.
Since RGS4 and Brn-2, a homolog of Brn3.2, have been identified
as target genes of Sim1 [13,27], their expression has been
investigated in MN9D cells transfected with pcDNA3::Sim1
expression vector and compared with the controls by qRT-PCR.
As illustrated in Fig. 6B, Sim1 overexpression in MN9D cells
resulted in a significant increase of RGS4 expression 24 h after
transfection (**p=0.003; n=3). This upregulation was however
transient, since 48 h and 72 h after transfection RGS4 expression
wasfoundcomparabletothe controls.Fig.6CrepresentsqRT-PCR
analysis for Brn3.2, in controls and Sim1 overexpressing cells. Brn3.2
mRNA expression level showed no significant differences between
the experimental groups 24 h after transfection. However, 48 h
after transfection, Brn3.2 was significantly upregulated in Sim1-
overexpressing cells, compared with the MN9D cells transfected
with pcDNA3 vector (**p=0.0023; n=3). Regulation of RGS4 and
Brn3.2 by Sim1 has been further investigated at the protein level by
immunoblotting (Fig. 6D) inhomogenate ofMN9D cells transfected
with pcDNA3::Sim1 expression vector and compared to the
controls, 48 h after transfection. The results show comparable
protein levels of RGS4 between controls and Sim1 overexpressing
cells, confirming the qRT-PCR data. In contrast, Brn3.2 protein
was found upregulated 48 h after transfecting MN9D cells with
pcDNA3::Sim1 expression vector, compared to the controls.
To assess whether the upregulated genes Brn3.2 and RGS4 were
expressed in rostral serotonergic neurons, in situ hybridization has been
performed on mouse fixed cryosections. Figs. 6E-6G illustrate coronal
sections from E14.5 mouse embryonic brain and Figs. 6H-6J, 6K, and
6M illustrate coronal sections from E18.5 mouse embryonic brain at
the level of pontine dorsal raphe (Fig. 6L). Using a Brn3.2 antisense
probe, at both E14.5 (E) and E18.5 (H) Brn3.2 was predominantly
expressed in areas of hindbrain lacking serotonergic neurons, thus
showing no co-localization with 5-HT, illustrated by immunofluores-
cence in the respective consecutive sections (Figs. 6F and 6I). Labeling
was considered specific, since incubation of the sections with sense
probe (K) revealed no detectable Brn3.2 labeling. In contrast, distinct 5-
HT immunoreactive neurons were additionally positive for RGS4,a t
E14.5 as well as at E18.5, as shown in Figs. 6G and 6J using an
antisense RGS4 in situ hybridization probe. However, RGS4
expression pattern was not restricted to 5-HT neurons. Other cell
types were positive for RGS4 as well. When sections were incubated
with RGS4 sense probe, no labeling could be detected (Fig. 6M).
RGS4, Brn3.2, and Pet1 are target genes of Sim1 in vivo
The results obtained from the Sim1 gain-of-function experi-
ments were further verified by Sim1 loss-of-function experiments.
Figure 4. Impact of Sim1 on protein abundance of early and late markers of the dopaminergic (A) and serotonergic (B) lineage.
Immunoblotting in homogenates of MN9D cells transfected either with pcDNA3::Sim1 or pcDNA3 expression vectors (ctl) 24 hours after transfection.
The immunoblots were probed either with an antibody against GAPDH or with Pitx3, TH, Pet1, or TPH2 antibody. Pitx3 and TH protein expression was
comparable between controls and pcDNA3::Sim1-transfected MN9D cells. In contrast, Pet1 and TPH2 protein abundance was significantly
upregulated in pcDNA3::Sim1-transfected MN9D cells, compared to the pcDNA3-transfected cells. (*P,0.05 after densitometric analysis of the signal
ratio Pet1:GAPDH or TPH2:GAPDH and Student’s t-test; n=3). The blots are representative for three different experiments. 30 mg protein was loaded
per lane.
doi:10.1371/journal.pone.0019239.g004
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PLoS ONE | www.plosone.org 6 April 2011 | Volume 6 | Issue 4 | e19239Figure 5. Differential regulation of serotonergic lineage determinants by Sim1. Quantitative real-time PCR analysis of Gata2 (A), Mash1 (B),
Pet1 (C) and Tph2 (D) mRNA levels in pcDNA3::Sim1-transfected MN9D cells and in pcDNA3-transfected cells. Expression of individual gene is shown
as 2
2DDCt6s. Gata2 and Mash1 expression remained unchanged in pcDNA3::Sim1-transfected MN9D cells, compared to pcDNA3-transfected cells
24 hours, 48 hours, and 72 hours after transfection. In contrast, Pet1 and Tph2 expression was significantly up-regulated in pcDNA3::Sim1-transfected
MN9D cells, compared to the controls 48 hours and 72 hours after transfection (*p,0.05; **p,0.01; and ***p,0.0001 using the Student’s t-test,
n=3).
doi:10.1371/journal.pone.0019239.g005
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specific siRNA, coupled to CY5. 24 h after transfection and
subsequent FACS, transfected cells were processed for total RNA
isolation, cDNA synthesis and subsequent qRT-PCR using Pet1,
Gata2, Brn3.2, Rgs4, and Tph2 specific primers. As shown in Fig. 7A,
Pet1, Gata2, Brn3.2, and Tph2 expression was significantly
downregulated 24 h after transfection of MN9D cells with Sim1
specific siRNA, compared to MN9D cells transfected with control
siRNA. In contrast, Rgs4 expression 24 h after downregulation of
Sim1 remained comparable with that of the controls. Together
with the gain-of-function results, these data suggest Pet1, Brn3.2
and Tph2 as downstream targets of Sim1 (*P,0.05 for Pet1, Gata2,
and Brn3.2, and **P,0.01 for Tph2, n=3).
The biological significance of the in vitro data has been further
validated in vivo. Therefore, we have used fixed brain tissue
sections from wt and Sim1-/- at P0 and performed in situ
hybridization for Pet1 (Figs. 7B-7E), RGS4 (Figs. 7F-7I) and Brn3.2
(Figs. 7J-7M). In sections from wt mice at P0, Pet1 mRNA
expression appeared distinct and of moderate intensity (Fig. 7B).
At higher magnification (Fig. 7C) the area of the DRN is clearly
positive for Pet1. In sections from Sim1-/- brains at P0, labeling for
Pet1 was decreased in DRN, as shown in Figs. 7D and 7E,
suggesting Pet1 as downstream target of Sim1. Similarly, as shown
in Figs. 7F-7I, RGS4 expression was detected in the area of rostral
serotonergic neurons in wt, whereas in Sim1-/- mutants (Figs. 7H
and 7I) RGS4 labeling was absent, demonstrating downregulation
in vivo. Brn3.2 mRNA expression is shown in Figs. 7J-7M. Although
Brn3.2 labeling of strong intensity could be observed in wt (Fig. 7J;
asterisks), the area of rostral serotonergic neurons, including dorsal
raphe nucleus (Figs. 7J arrow, and 7K), and other raphe nuclei,
were devoid of Brn3.2 expression. In Sim1-/- (Figs. 7L and 7M)
Brn3.2 expression was completely abolished, demonstrating that
Brn3.2 is a target gene of Sim1 as well.
Finally, to validate the mRNA data at the protein level, protein
extraction has been performed from 4%-fixed cryosections from
hindbrain of wt and Sim1-/- mutants, as described in Material and
Methods,followed by westernblot analysis. Asillustrated inFig.7N,
Pet1, RGS4 and Brn3.2 protein abundance was significantly
downregulated in Sim1-/- compared to the wt (0.5760.25 fold,
*p=0.032, 0.6760.12, *p=0.048 and 0.7060.05, *p=0.044, for
Pet1, Rgs4 and Brn3.2, respectively, n=4,)
Discussion
In the present study we have addressed the question whether the
mouse homologue of the Drosophila sim, mSim1, might be
involved in the differentiation of two clinically important ventral
neuronal populations, namely the mDA and rostral 5-HT
neurons. These neuronal subpopulations reveal positional and
developmental relationships and share common transcriptional
determinants during their differentiation and specification.
After having shown that Sim1 is expressed in TH positive and 5-
HT immunoreactive cells, we further investigated the biological
significance of Sim1 during the development of mDA and 5-HT
neurons in vivo, by examining Sim1 deficient mice at E14.5 and P0.
Since Sim1 mutants die shortly after birth due hypothalamic
developmental defects [27,28], an investigation in adult animals
was not possible. Our results demonstrate comparable number of
mDA in Sim1 mutants and wild type at both stages examined. In
contrast, Sim1 has been shown to be involved in the differentiation
of zebrafish diencephalic A11-related dopaminergic neurons [29].
Gene ablation of Sim1 had no effect on the total number of rostral
5-HT neurons at E14.5 as well, a time point in which individual
rostral nuclei raphe cannot be distinguished. However, in Sim1-/-
newborn mice the number of 5-HT neurons in the dorsal raphe
nucleus (DRN) was significantly decreased by 30% (Fig. 2J), but
not in the median and paramedian raphe, demonstrating a
selective effect of Sim1 on a rostral serotonergic subpopulation.
The serotonergic system is involved in the modulation and
coordination of a variety of autonomic functions and behaviour,
including the sleep-wake cycle, aggression, anxiety, mood, and
stress. Besides, or even due to, its different functions the
serotonergic system is characterized by extensive and complex
cellular heterogeneity. First, 5-HT neurons consist of nine cell
groups (B1-B9) that are separated into two clusters, the rostral (B5-
B9) and caudal (B1-B4) nuclei raphe. Second, rostral and caudal 5-
HT neurons are differentially regulated by developmentally potent
signaling molecules, such as TGF-b [30], and also exhibit different
electrophysiological properties, suggesting that they likely repre-
sent developmentally and functionally distinct neuronal subpop-
ulations. Moreover, even within a given raphe nucleus individual
cell subpopulations exist, characterized by different developmental
background and topographically organized efferent projections. In
particular, the neurons of DRN vary considerably with regard to
their synaptic morphology and their electrophysiological proper-
ties from each other [31,32]. The DRN of the brainstem is the
main source of serotonergic innervation of limbic structures
fundamental in the regulation of emotionally influenced behav-
iour. Interestingly, serotonergic neurons that innervate the central
nucleus of the amygdala, and subsequently exert a modulatory
action on the vegetative centers of the hypothalamus, are restricted
Figure 6. Identification of candidate genes involved in the development of serotonergic neurons. A: Quantitative real-time PCR analysis
showed that expression of the transcription factors Brn3.2 and Lhx8, and of a regulator of G protein signalling and modulator of 5-HT1A-mdiated
neurotransmitter release, RGS4, are significantly upregulated in mouse ventral hindbrain tissue compared to ventral midbrain primary tissue at
embryonic day 11.5. B-C: Regulation of expression of candidate genes by Sim1, assessed by quantitative real-time PCR. Rgs4 (B) and Brn3.2 (C) mRNA
levels in pcDNA3::Sim1-transfected MN9D cells and in pcDNA3-transfected cells were analyzed. Expression of individual gene is shown as 2
2DDCt6s.
Rgs4 and Brn3.2 expression was significantly up-regulated 24 hours and 48 hours, respectively, after transfection of MN9D cells with pcDNA3::Sim1
expression vector, compared with the controls (**P,0.01, using the Student’s t-test, n=3). D: Immunoblotting for RGS4 and Brn3.2 protein
abundance in homogenates of MN9D cells transfected either with pcDNA3::Sim1 or pcDNA3 expression vectors (ctl) 48 hours after transfection. The
immunoblots were probed either with monoclonal antibody against GAPDH or with a goat polyclonal antibody against RGS4 or Brn3.2. RGS4 protein
expression was comparable between controls and pcDNA3::Sim1-transfected MN9D cells. In contrast, Brn3.2 protein abundance was significantly
upregulated in pcDNA3::Sim1-transfected MN9D cells, compared to the pcDNA3-transfected cells. (**p,0.01 after densitometric analysis of the signal
ratio Brn3.2: GAPDH and Student’s t-test; n=3). The blots are representative for three different experiments. 30 mg protein was loaded per lane. E, G:
In situ hybridization for expression of candidate genes in mouse at E14.5 using antisense probes. Brn3.2 expression was present in hindbrain, but not
in the area of rostral serotonergic neurons (E), whereas RGS4 expression was detectable in rostral serotonergic neurons (G). F: immunofluorescence
for 5-HT at E14.5. H, J: In situ hybridization for expression of candidate genes in mouse at E18.5 using antisense probes. Brn3.2 expression was present
in hindbrain, but not in the area of rostral serotonergic neurons (H), whereas RGS4 expression was detectable in rostral serotonergic neurons (J). I:
immunofluorescence for 5-HT at E18.5. K, M: In situ hybridization at E18.5 for expression of Brn3.2 (K) and RGS4 (M) using sense probes revealed no
detectable staining. L: schematic presentation of a sagittal section of mouse brain at E18.5 with a line drawn to indicate the approximate level of
brain sections used for H-M (r: rostral, c: caudal). Aq: aqueduct.
doi:10.1371/journal.pone.0019239.g006
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PLoS ONE | www.plosone.org 9 April 2011 | Volume 6 | Issue 4 | e19239Figure 7. Sim1 loss-of-function in vitro and in vivo. A: Quantitative real-time PCR analysis for candidate genes in MN9D cells transfected either
with control siRNA (ctl) or with specific Sim1 siRNA. Gene expression is shown as 2
2DDCt6s. Pet1, Gata2, Brn3.2, and Tph2, but not RGS4 expression was
significantly down-regulated in Sim1 siRNA-transfected cells, compared to the controls, 24 hours after transfection (*p,0.05 and **p,0.01, using the
Student’s t-test, n=3). B-M: In situ hybridization for Pet1 (B-E), RGS4 (F-I) and Brn3.2 (J-M) in wild type (wt) and Sim1-/- mutants at P0. Pet1 expression
was observed in the area of rostral 5-HT neurons (B) including the area of dorsal raphe in wt (C: magnification of the inset in B), but was considerably
decreased in Sim1-/- (D). E: magnification of the inset illustrating the area of the dorsal raphe. RGS4 (F, and magnification of the inset in G) was also
expressed in the dorsal raphe in wt, and was considerably decreased in Sim1 mutants (H and magnification of the inset in I). In contrast, although
Brn3.2 expression in wt was present (J, asterisks) the area of rostral 5-HT neurons was devoid of Brn3.2 expression (J, arrow and magnification of the
inset in K). In Sim1-/- mutants Brn3.2 expression was absent (L, and magnification of the inset in M). N: immunoblot analysis for Pet1, RGS4, and Brn3.2
in hindbrain of wt and Sim1-/- mutants. Pet1, RGS4, and Brn3.2 protein abundance was significantly downregulated in Sim1-/- hindbrain, compared to
wt. (*p,0.05 after densitometric analysis of the signal ratio Pet1:GAPDH, RGS4:GAPDH or Brn3.2:GAPDH and Student’s t-test; n=4). The blots are
representative for four different experiments. 30 mg protein was loaded per lane.
doi:10.1371/journal.pone.0019239.g007
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observed loss of DRN 5-HT neurons in Sim1 mutants is restricted
to a distinct neuronal subpopulation within this nucleus is not
clear. Nevertheless, our results provide evidence that differential
developmental transcriptional networks likely correspond to each
neuronal subpopulation. Elucidation of the putative mechanism
underlying Sim1 effects on rostral 5-HT neurons has been
performed by gain- and loss-of-function experiments using the
MN9D cells line as a culture system. The gene expression analysis
performed in the present study (Fig. 3A) clearly demonstrates that
these cells express determinants of the serotonergic lineage,
represented by Gata2, Pet1, and TPH2. The transcription factor
Pet1 together with Lmx1b, Nkx2.2, Mash1, Gata2, Gata3, and Phox2b
form a transcriptional network, which specifies the differentiation
of serotonergic neurons from hindbrain progenitors at E11 in the
mouse. According to the current view for serotonergic neurons
differentiation, Phox2b is switched off at E10.5. Together with
Mash1 and Nkx2.2, the transcription factors Gata3, Gata2, Lmx1b,
and Pet1 are activated, which subsequently define the cell fate by
activating serotonergic lineage marker genes, such as TPH2.
However, phenotype analyses from gene ablations studies have
demonstrated that the suggested transcriptional network is still not
complete and additional determinants are involved in the
specification of rostral 5-HT neurons. Based on the results of the
in vitro experiments, several lines of evidence propose Sim1 as a
putative novel determinant in the transcriptional network
orchestrating 5-HT neuron development. Sim1 overexpression
did not affect expression of Gata2 though (Fig. 5A), a mitotic and
postmitotic marker for rostral serotonergic neurons. This obser-
vation is quite surprising, since in a previous study in Neuro2A
cells Gata2 has been identified as a downstream target of Sim1
[22]. Along this line, transfection of MN9D cells with specific Sim1
siRNA significantly downregulated Gata2 expression (Fig. 7A),
demonstrating a role of Sim1 in maintenance of Gata2 expression.
Sim1 overexpression had no effect on Mash1 as well, an early
determinant of the transcriptional network underlying 5-HT
development [9]. By contrast, Sim1 was able to activate Pet1 and
Tph2, late markers specific for the serotonergic lineage. Both Pet1
and Tph2 were significantly upregulated after Sim1 overexpres-
sion, and significantly downregulated after transfection of MN9D
cells with specific Sim1 siRNA, implicating Pet1 and Tph2 as
putative downstream targets of Sim1. Moreover, conserved Pet1
binding sites are present in the promoter of several genes
characteristic for the serotonergic phenotype, among them
TPH2 [11], thus suggesting a putative alternative indirect cascade
for Tph2 activation, by means that Tph2 regulation by Sim1 occurs
secondarily through Pet1. In addition, in Sim1-/- only a
subpopulation of 5-HT neurons was affected, and in Pet1-/-
mutants 5-HT neurons were dramatically decreased but not
completely lost, strongly suggesting that more than one pathway
should be involved in the differentiation of 5-HT neurons. It is
conceivable that Pet1 can be regulated by multiple transcription
inputs at different subpopulation of 5-HT neurons. Along this line,
we have revealed that for the dorsal raphe nucleus Sim1 is a crucial
regulator. Notably, it has recently been shown that Pet1-
dependent and Pet-1-resistant 5-HT neurons exist, that have
different morphological features, including targeting of different
brain areas and formation of synaptic junctions [34].
We have also demonstrated that RGS4, Lhx8, and Brn3.2,a l l
downstream targets of Sim1, are significantly upregulated in mouse
E11.5 ventral hindbrain, compared to ventral midbrain (Fig. 6A). Sim1
overexpression in MN9D cells significantly upregulated RGS4 (Fig. 6B).
Consistently, RGS4 expression (Figs. 7H, 7I) and protein abundance
(Fig. 7N) was downregulated in hindbrain of Sim1-/- mutants. This
result confirms and extends previous observations, in which expression
of RGS4 is downregulated in hypothalamic domains in Sim1-/- mice
[27]. Although the in vivo roles of RGS4 are not fully understood, it has
been identified to have the capacity to modulate neurotransmitter
receptors in the rat brain. Interestingly, RGS4 modulates 5-HT1A-
mediated neurotransmitter release, in vitro and in vivo [35,36]. In the
context of the present work, this observation is of particular interest,
since 5-HT1A represent the autoreceptors in the DRN. Taken into
consideration that 5-HT can also affect differentiation, RGS4
expression during early 5-HT neuron development could be critical
for terminal differentiation of dorsal raphe 5-HT neurons. Indeed, as
shown in Figs. 6G and 6J, a colocalization of 5-HT and RGS4 in vivo
was apparent in mouse hindbrain.
In addition, after Sim1 overexpression, expression of a class IV
POU domain transcription factors member, Brn3.2 (POU4F2),
was found upregulated as well (Fig. 6C, 6D). Members of the class
IV POU domain proteins are required for normal differentiation
and survival of several neuronal populations [37]. The present
study provides first evidence that Brn3.2 is downregulated in
Sim1-/- mutants (Figs. 7L, 7M, 7N). However, Brn3.2 expression
was restricted to areas of the hindbrain outside the serotonergic
system, suggesting that differentiation of other neuronal subpop-
ulations of the hindbrain, but not 5-HT neurons, might be
controlled by Brn3.2. In contrast, Brn-2 (also known as POU3F2)
has been identified to act downstream of Sim1 during anterior
hypothalamus development [20], and has been shown to be
expressed in rat adult DRN, where it colocalizes with TPH2.
Importantly, Brn-2 activates the Tph2 promoter [38]. These
observations, together with results of the present study, where
Sim1 overexpression upregulated Tph2 expression (Fig. 5D),
suggest a putative interaction of Sim1 with Tph2 via Brn-2 and
provide an attractive scenario for putative mechanisms underlying
the phenotype observed in Sim1 -/- newborn mice.
Reduced expression of serotonergic markers such as TPH2
resembles observations obtained in the dopaminergic system of
zebrafish, where in the absence of Arnt2/Sim1 function, the
dopaminergic markers th, dat and ddc were reduced in posterior
tuberculum and hypothalamus [29]. Taken into consideration that
Sim1 has been described as a transcriptional repressor, further
studies are needed to clarify the molecular interactions and
pathways leading to activation of transcription factors involved in
the terminal specification of serotonergic neurons. As an example,
another possible scenario could imply that Sim1 may act indirectly
by repressing inhibitors of serotonergic lineage.
In conclusion,the resultsof the present studystronglysuggest Sim1
involvement in terminal differentiation of rostral 5-HT phenotype in
at least two different processes.First,Sim1actson the development of
the DRN through a developmental pathway leading to Tph2
activation via Brn-2, additionally or alternatively via Pet1.S e c o n d ,
Sim1 acts to modulate serotonin release of the B7 group of 5-HT
neurons via regulating RGS4.A sRGS4 is only transiently up-
regulated by Sim1, there likely exists a feedback loop to maintain a
proper level of RGS4 and hence the homeostasis of serotonin release.
Our study underscores that subpopulation of a common neurotrans-
mitter phenotype use distinct combinations of transcription factors to
control the expression of shared properties i.e. Pet1 and Tph2.
Materials and Methods
This study was carried out in strict accordance with the
National Health and ethical regulations and care of animals was in
accordance with institutional guidelines. The protocol was
approved by the Committee on the Ethics of Animal Experiments
of the University of Freiburg (Permit Number: X-07/27A).
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and all efforts were made to minimize suffering.
RT-PCR
Total RNA was isolated from tissue of mouse ventral midbrain,
ventral hindbrain, and isthmus, reverse transcribed and processed
for PCR [39]. The forward and reverse primer sequences used are
listed in Table 1.
For detection of cDNAs encoding the respective proteins,
following protocol was used: denaturation at 95uC for 5 minutes,
the optimum number of cycles -depending on primer pair- of PCR
amplification were performed at following conditions: denatur-
ation at 94uC for 1 minute, annealing at appropriate temperature
for 1 minute, and elongation at 72uC for 1 minute. Final extension
at 72uC for 10 minutes was terminated by rapid cooling at 4uC.
Cell culture
The MN9D cell line, a hybridoma cell line established by fusing
embryonic primary cells from mouse ventral midbrain with cells
from the mouse neuroblastoma cell line N18TG2 [25] was used
for in vitro experiments. Cells were cultured in DMEM/F-12 1:1,
supplemented with 5% FCS, and 50 mg/ml gentamycin, passaged
when confluent, and incubated in a 95% air /5% CO2
atmosphere at 37uC. One day before transfection cells were
plated at a density of 1610
6 cells in 25 cm
2 flasks. Cells were
transfected with expression vectors pcDNA3 or pcDNA3::Sim1,
6 mg of plasmid DNA per flask. Transfection was performed with
Lipofectamine (Invitrogen, Karlsruhe, Germany) according to the
manufacturer’s protocol. After 4 h of incubation with DNA
precipitate, complete medium containing 5% FCS was added.
24 h, 48 h, and 72 h post transfection cells were harvested and
probes were processed for either RNA isolation and subsequent
qRT-PCR or immunoblotting.
Alternatively, cells were seeded at 1610
6 cells in 25 cm
2 flasks
and transiently transfected with CY5-labeled siRNA targeting
mouse Sim1 mRNA (purchased from Qiagen). The siRNA was
transiently transfected into MN9D cells with 750 ng siRNA in
30 ml HiPerFect reagent (Qiagen). A sequence that reveals no
homology with any known mammalian genes has been labeled
with Alexa 488 and was used as control siRNA. Cells were
harvested and lysed 24 h after transfection, and gene expression
was analyzed by qRT-PCR.
FACS analysis of transfected MN9D cells with Sim1 siRNA
MN9D cells successfully transfected either with CY5-labeled
siRNA targeting mouse Sim1 or with control siRNA labeled with
Alexa 488 were analyzed by flow cytometry. Briefly, MN9D cells
were sedimented (820 g, 10 minutes, 4uC), resuspended with
DMEM-F12, containing 2% FCS and 10 mM HEPES. Cells were
incubated at 37uC for 90 minutes, centrifuged, and resuspended
with HBSS containing 2% FCS and 10 mM HEPES. Cells were
then processed for RNA isolation and subsequent qRT-PCR.
Real-Time PCR
Total RNA was isolated from MN9D cells transiently
transfected with either pcDNA3 or pcDNA3::Sim1 expression
vectors and subsequently 1.0 mg was reverse-transcribed. The
primers used for qRT-PCR are listed in Table 1.
Table 1. Primer sequences used for RT-PCR gene expression analysis.
Primer Accession PCR-fragment
Gapdh F: 59-CGGCCGCATCTTCTTGTG-39 NM008084 nt 804-1210
Gapdh R: 59-TGACCAGGCGCCCAATAC-3
Nestin F: 59-CAGGCTTCTCTTGGCTTTCCTG-39 NM016701 nt 1074-1512
Nestin R: 59-GGTGAGGGTTGAGGGGTGG-39
Gata 2F :5 9-CACCCCGCCGTATTGAATG-39 NM008090 nt 37-147
Gata 2 R: 59-CCTGCGAGTCGAGATGGTTG-39
Mash1 F: 59-ACTTGAACTCTATGGCGGGTT-39 NM008553 nt 584-690
Mash1 R: 59-CCAGTTGGTAAAGTCCAGCAG-39
Pet1 F: 59- AGCAAGCCTAACATGAACTACG NM153111 nt 484-593
Pet1 R: 59-AAGTCAAAGCGGTAGGCG-39
Sim1 F: 59-CTTTCTTTTATACTTACACCTCACGTTTTC-39 NM011376 nt 37-152
Sim1 R: 59-AACATAACTTTAAACAGGAGGCTGAAG-39
Sim1 F: 59-TGAAGTGTGTTTTGGCCAAGC-39 NM 011376 nt 736-1052
Sim1 R: 59-ATGCACGTGATGGTACAGGGT-39
Tph2 F: 59-AAGTCGAAATCTTCGTGGACTG-39 NM173391 nt 432-531
Tph2 R: 59-GGCGGATTCAGGGTCACAAT-39
Brn3.2 F: 59-ACATCGTCTCCCAGAGTAAGAG-39 NM138944.2 nt 607-703
Brn3.2 R: 59-CACGGGATGGTGTTCTGG-39
Lhx8 F: 59-ACACGAGCTGCTACATTAAGGA-39 NM010713.2 nt 606-716
Lhx8 R: 59-CCCAGTCAGTCGAGTGGATG-39
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Cycle conditions: denaturation at 95uC for 10 minutes, and 40
cycles of PCR amplification at 95uC for 30 seconds and 56uC for
30 seconds and elongation at 72uC for 1 minute. All PCRs were
performed in triplicate on an ABI PRISM 7500 Sequence
Detection System.
The mean 6 SD of the Ct values for the genes of interest and
GAPDH were determined and statistically analyzed using the
Student’s t-test. *p,0.05 was considered as statistically significant.
For documentation of the data, relative mRNA levels were




MN9D cells were harvested and homogenized, and protein
concentration was determined according to Bradford [41]. For
isolating proteins from hindbrain of 4%-PFA fixed brain cryosec-
tions from wildtype and Sim1-/- mutants, the method described by
Scicchitano et al., [42] has been applied, using the Qproteome
FFPE Tissue Kit from Qiagen, following the manufacturer’s
instructions. After determination of protein concentration, electro-
phoresis and blotting procedures were performed as described [43].
Blots were incubated with primary antibody overnight at dilution
1:1,000 for Sim1 (rabbit polyclonal; Chemicon; raised against
amino-acids 423-435 of human Sim1), 1:1,000 for TH (mouse
monoclonal, Chemicon, Hofheim, Germany), 1:500 for Pitx3
(rabbit polyclonal; Chemicon), 1:1,000 for TPH2 (mouse monoclo-
nal, Sigma, Taufkirchen, Germany;), 1:1,000 for Pet1 (rabbit
polyclonal, Abcam, Cambridge, UK), 1:500 for RGS4 and Brn3.2
(goat polyclonal, from Santa Cruz), and 1:10,000 for GAPDH
(mouse monoclonal, Abcam). After incubation with secondary
antibodies, blots were developed in enhanced chemiluminescence
reagents and signals were visualized on X-ray film. Subsequently,
films were scanned and the signal ratio TH:GAPDH, Pitx3:-
GAPDH, TPH2:GAPDH, Pet1:GAPDH, RGS4:GAPDH and
Brn3.2:GAPDH was quantified densitometrically. Differences in
signal ratio were tested for significance using Student’s t-test. Results
with levels of *p,0.05 were considered significant.
Animals
The generation of Sim1-/- mice has been described previously
[20]. For morphological comparison wild type littermates were
used as wild type controls. The morning of the day on which a
vaginal plug was detected in mating was designated gestation day
0.5. Analysis was performed on 4% paraformaldehyde-fixed 14.5-
day-old embryos (E14.5) and in newborn mice (P0). For
immunohistochemistry experiments embryos or heads of newborn
mice were dehydrated, embedded in paraffin, and cut into 10 mm
serial sections. For in situ hybridization, they were cryoprotected
and cut into 10 mm cryosections.
Immunohistochemistry
Immunohistochemistry has been performed as described earlier
[43]. Monoclonal mouse anti-TH (1:100; Chemicon), rabbit
polyclonal anti-5HT antibody (1:1,000; Sigma) or rabbit poly-
clonal anti-Sim1 (1:400) were used as primary antibodies and goat
anti-mouse or goat anti-rabbit IgG coupled to either horseradish
peroxidase, or FITC as secondary antibodies.
Numbers of TH- and 5-HT-labeled neurons were counted on
the complete series of 10 mm transverse sections after immunoper-
oxidase and immunofluorescence staining. A neuron was desig-
nated as TH or 5-HT positive if it revealed a darkly labeled
cytoplasm and a clearly visible, unstained nucleus. Only cells
fulfilling these criteria were included in the cell counts. To avoid
double counting the same cell on two sequential sections, only
every fifth section was counted.
In situ hybridization
Non-radioactive in situ hybridization on cryosections and
preparation of digoxigenin-labelled probes for RGS4 [35], Pet1
[11] and Brn3.2 [44] were carried out as described by Ernsberger
et al. [45].
Statistics
Data are presented as the mean 6 SD. Statistical analysis was
performed using the Student’s unpaired t-test. Differences were
considered statistically significant at *p,0.05, **p,0.01 and
***p,0.001.
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